Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 74 | 0 | 11 | 0 | €801.50 | €831.01 | 3.682% |
| Vertex Pharmaceuticals Inc. | 58 | 2 | 1 | 0 | €413.95 | €439.34 | 6.135% |
| Regeneron Pharmaceuticals Inc. | 53 | 1 | 7 | 0 | €922.80 | €1,080.6 | 17.101% |
| Insmed Inc. | 46 | 0 | 2 | 0 | €64.50 | €76.89 | 19.202% |
| Alnylam Pharmace. | 44 | 0 | 3 | 0 | €243.00 | €275.25 | 13.272% |
| Johnson & Johnson | 41 | 1 | 6 | 0 | €145.58 | €192.63 | 32.319% |
| Intra-Cellular Therapies Inc. | 36 | 0 | 5 | 0 | €65.00 | €85.14 | 30.989% |
| Cytokinetics Inc. | 37 | 1 | 5 | 0 | €50.50 | €82.73 | 63.814% |
| Acadia Pharmaceuticals | 36 | 1 | 1 | 0 | €14.05 | €29.92 | 112.997% |
| AbbVie Inc. | 33 | 0 | 0 | 0 | €177.06 | €181.45 | 2.478% |
| Jazz Pharmaceuticals plc | 33 | 0 | 3 | 0 | €98.22 | €182.69 | 86.000% |
| Merck & Co. Inc. | 32 | 1 | 2 | 0 | €99.90 | €126.38 | 26.507% |
| United Therapeutics | 29 | 1 | 2 | 0 | €321.60 | €341.70 | 6.249% |
| Amgen Inc. | 29 | 1 | 3 | 1 | €290.50 | €304.82 | 4.929% |
| Ultragenyx Pharmaceutical Inc. | 29 | 1 | 5 | 0 | €49.00 | €82.93 | 69.247% |
| Icon plc | 27 | 0 | 5 | 0 | €269.00 | €327.46 | 21.733% |
| Halozyme Therapeutics Inc. | 25 | 0 | 4 | 0 | €53.90 | €58.58 | 8.679% |
| Trinity Biotech ADR | 25 | 0 | 0 | 0 | €0.41 | - | - |
| Pfizer Inc. | 29 | 4 | 5 | 0 | €25.98 | €40.64 | 56.409% |
| Novo Nordisk A/S ADR | 25 | 1 | 4 | 0 | €104.50 | €144.48 | 38.258% |
| Celldex Therapeutics | 23 | 0 | 6 | 0 | €28.00 | €62.17 | 122.033% |
| Abbott Laboratories | 22 | 0 | 3 | 0 | €102.48 | €116.48 | 13.661% |
| Exelixis Inc. | 22 | 0 | 4 | 0 | €23.95 | €26.01 | 8.586% |
| Zoetis Inc. A | 22 | 1 | 1 | 0 | €173.50 | €196.17 | 13.064% |
| Pacira Pharmaceuticals | 22 | 1 | 1 | 0 | €14.10 | €40.02 | 183.830% |